mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.003 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.003 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.004 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |